Honz Pharmaceutical Co., Ltd., is a publicly listed company centered on medicines for children. It devotes to becoming the leading brand in the children’s healthcare industry in China.
Scientific Research Achievements
“The development and industrialization of Itraconazole dispersible tablet”awarded 2nd prize in 2016 Hainan scientific and technology achievement transformation event
Medication for children with hand-foot-mouth disease - suramin sodium for injection - completed clinical research and declared for clinical application
Children’s medication - dextromethorphan hydrobromide film agent approved for clinical test
Hainan key sci-tech project - The development and industrialization of Levocetirizine Hydrochloride Granules was checked and accepted
The establishment of“Hainan Engineering Technology Research Centre for Children’s Medication”was approved by Hainan Science & Technology Department
Approved for 8 clinical tests including Ibuprofen phenylephrine Tablet,Ibuprofen Suspension Drops,Paracetamol Oral Suspension Fluid, Cefprozil for Suspension Drops, etc.
Levocetirizine Hydrochloride Granules obtained Pharmaceutical Registration Approval Document and started mass production
Accomplish establishment of 3 technology platforms for Post Doctoral Research Institute: Membrane instant dissolving technology for oral cavity; Crystallization and granulation of supercritical fluid; Medication Powdery characterization. It has laid a solid scientific foundation for the corporate to build up an international standard children’s medication base; and also ensure Honz Pharma products’taste and other technical indicators maintain advantage in the same kind of products.
Ceftazidime tazobactam sodium for injection - assessed to be National Key New Product
Ceftazidime tazobactam sodium for injection - assessed to be Hainan New Hi-tech Project
“The development and industrialization of Nimesulide Granules”awarded 2nd prize in 2012 Hainan scientific and technology achievement transformation event
I Grade new medication- Ceftazidime tazobactam sodium for injection - obtained Pharmaceutical Registration Approval Document and started mass production
Took the lead in the establishment of National Post Doctoral Research Institute; choosing children's medication as the main research direction
Itraconazole dispersible Tablet and Nimesulide Granules are assessed to be Hainan New Hi-tech products
ZHIKE JUHONG Granules is assessed to be Haikou New Hi-tech Project
“The development and industrialization of ZHIKE JUHONG KELI”awarded 2nd prize in 2013 Hainan scientific and technology achievement transformation event
“The Manufacture Method of Nimesulide Sustained-release Tablets”patent won the gold medal in Haikou Patent Awards
Identified as provincial-level technology corporate center by Hainan Industrial & Information Technology Department, Hainan Science & Technology Department and 4 other departments
The establishment of“Haikou Pediatric Pharmaceutical Engineering & Technology Research and Development Centre" was approved by Haikou Science & Information Technology Bureau